In this episode, Frank Gleeson, CEO and co-founder of Satellos, and Dr Michael Rudnicki, co-founder and Chief Discovery Officer at Satellos, discuss how new insights into stem cell biology are leading to novel therapeutics in regenerative medicine beyond cell therapy.
They share how new insights into stem cell biology are leading to novel therapeutics in regenerative medicine beyond cell therapy, focusing on degenerative muscle diseases.
Listen to the podcast here.
